Importantly, we have found clinically meaningful ROR1 expression—highly frequent and moderately intense ROR1 expression—in mesothelioma and moderately frequent and lower intensity ROR1 expression—in liposarcoma. This evidence concerns the gene ROR1 and liposarcoma.